PECAM1 and neoplasm: In 39/40 tumors▪DLL4+ and CD31+▪30% VEGFR2+ vessels ∞ N1 and N3 ICD in tumor, NOTCH3 and DLL4 in vessels▪No ∞ NOTCH biomarkers and time to progression